Company sells 1.3 million common shares at $3.00 per share
By Devika Patel
Knoxville, Tenn., Oct. 1 - Oragenics, Inc. settled a $3.9 million private placement of stock with Intrexon Corp. on Sept. 30, according to an 8-K filed Tuesday with the Securities and Exchange Commission.
The company sold 1.3 million common shares at $3.00 apiece. The price per share is identical to the Sept. 27 closing share price.
Proceeds will be used for development of the company's key initiatives and general corporate purposes.
Oragenics is an Alachu, Fla.-based biopharmaceutical company.
| Issuer: | Oragenics, Inc.
|
| Issue: | Common stock
|
| Amount: | $3.9 million
|
| Shares: | 1.3 million
|
| Price: | $3.00
|
| Warrants: | No
|
| Agent: | Intrexon Corp.
|
| Settlement date: | Sept. 30
|
| Stock symbol: | Amex: OGEN
|
| Stock price: | $3.00 at close Sept. 27
|
| Market capitalization: | $84.74 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
